Hybridomas, which produce monoclonal antibodies, are made by fusing cells of the immune system with B lymphocytes and myeloma cells.
<h3>
What are Hybridomas?</h3>
- Large-scale production of monoclonal antibodies is made possible through hybridoma technology.
- An antigen that triggers an immune response is first injected into a mammal to begin the process.
- A specific sort of white blood cell called a B cell makes antibodies that bind to the antigen that has been injected.
- These antibody-producing B-cells are then removed from the animal and combined with immortal B cell cancer cells, or myeloma, to create a hybrid cell line known as a hybridoma.
- It possesses both longevity and procreative capacity of the myeloma and the antibody-producing capacity of the B-cell.
Hence, the creation of hybridomas, which result in the production of monoclonal antibodies, involves fusing immune system cells with B lymphocytes and myeloma cells.
To learn more about Hybridomas refer to:
brainly.com/question/15189667
#SPJ4
a sudden, sometimes temporary, cessation of function of the heart.
The nurse will perform pulse oximetry to monitor the effectiveness of the oxygen therapy ordered for the client.
<h3>What is pulse oximetry?</h3>
The oxygen saturation level of your blood can be measured with a non-invasive procedure called pulse oximetry.
It can quickly identify even minute variations in oxygen levels. These levels demonstrate how well blood transports oxygen to your arms and legs, which are the extremities that are farthest from your heart. It looks like a little clip and is called a pulse oximeter. It fastens to a body component, usually a finger.
Pulse oximetry is helpful for postoperative patients, monitoring individuals at risk for hypoxia, titrating oxygen therapy, and monitoring patients receiving oxygen therapy.
Learn more about pulse oximetry here:
brainly.com/question/8340469
#SPJ4
